2 Followers USX:BTAI - BioXcel Therapeutics Inc

BioXcel Therapeutics Inc
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts
• Charts
• Options

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2016 Q4	2017 Q1	2017 Q2	2017 Q3	2017 Q4	2018 Q1	2018 Q2	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0 -	0 -	0 -	0 -	0 -	137K -	375K 173.7%	581K 54.9%	1.04M 78.7%	1.24M 19.7%	1.38M 11.1%	1.76M 27.2%
Cost of Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	0 -	0 -	0 -	0 -	11K -	20K 81.8%	29K 45%	54K 86.2%	555K 927.8%	1.26M 127.0%	1.33M 5.6%
Gross Profit	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	0 -	0 -	0 -	0 -	126K -	355K 181.7%	552K 55.5%	984K 78.3%	687K -30.2%	120K -82.5%	425K 254.2%
Total Expenses	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	99.86M 6.6%	101.9M 2.0%	106.94M 4.9%	112.04M 4.8%	120.71M 7.7%	133.02M 10.2%	160.02M 20.3%	179.94M 12.5%	196.53M 9.2%	201.88M 2.7%	169M -16.3%	142.34M -15.8%
Operating Expense	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	99.86M 6.6%	101.9M 2.0%	106.94M 4.9%	112.04M 4.8%	120.71M 7.7%	133.01M 10.2%	160M 20.3%	179.91M 12.4%	196.47M 9.2%	201.32M 2.5%	167.74M -16.7%	141.01M -15.9%
Operating Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-99.86M -	-101.9M -	-106.94M -	-112.04M -	-120.71M -	-132.88M -	-159.65M -	-179.36M -	-195.49M -	-200.64M -	-167.62M -	-140.58M -
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-99.83M -	-101.89M -	-106.93M -	-112.03M -	-122.08M -	-137.07M -	-165.76M -	-187.08M -	-202.93M -	-211.6M -	-179.05M -	-153.05M -
Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-99.83M -	-101.89M -	-106.93M -	-112.03M -	-122.08M -	-137.07M -	-165.76M -	-187.08M -	-202.93M -	-211.6M -	-179.05M -	-153.05M -
Basic EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-4.12 -	-3.98 -	-4.05 -	-4.09 -	-4.34 -	-4.88 -	-5.92 -	-6.64 -	-7.13 -	-7.36 -	-6.15 -	-5.18 -
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-4.12 -	-3.98 -	-4.05 -	-4.09 -	-4.34 -	-4.88 -	-5.92 -	-6.64 -	-7.13 -	-7.36 -	-6.15 -	-5.18 -